1. Home
  2. DAL vs KVUE Comparison

DAL vs KVUE Comparison

Compare DAL & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delta Air Lines Inc.

DAL

Delta Air Lines Inc.

HOLD

Current Price

$64.71

Market Cap

38.2B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.54

Market Cap

34.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAL
KVUE
Founded
1924
2022
Country
United States
United States
Employees
78400
N/A
Industry
Air Freight/Delivery Services
Specialty Chemicals
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.2B
34.9B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
DAL
KVUE
Price
$64.71
$17.54
Analyst Decision
Strong Buy
Buy
Analyst Count
19
11
Target Price
$77.42
$19.73
AVG Volume (30 Days)
13.4M
22.7M
Earning Date
04-08-2026
05-07-2026
Dividend Yield
1.12%
4.72%
EPS Growth
43.71
40.74
EPS
7.66
0.76
Revenue
$41,244,000,000.00
$15,124,000,000.00
Revenue This Year
$0.40
$4.82
Revenue Next Year
$5.01
$2.61
P/E Ratio
$8.73
$23.12
Revenue Growth
N/A
N/A
52 Week Low
$34.74
$14.02
52 Week High
$76.39
$25.17

Technical Indicators

Market Signals
Indicator
DAL
KVUE
Relative Strength Index (RSI) 49.15 41.25
Support Level $64.47 $17.13
Resistance Level $72.32 $17.52
Average True Range (ATR) 2.01 0.26
MACD 0.76 -0.03
Stochastic Oscillator 64.58 20.99

Price Performance

Historical Comparison
DAL
KVUE

About DAL Delta Air Lines Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: